UBS Group’s BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. DCF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-130,782
| Closed | -$1.2M | – | 10783 |
|
|
2024
Q3 | $1.2M | Buy |
130,782
+82,785
| +172% | +$746K | ﹤0.01% | 4494 |
|
|
2024
Q2 | $425K | Sell |
47,997
-2,656
| -5% | -$22.9K | ﹤0.01% | 5129 |
|
|
2024
Q1 | $436K | Sell |
50,653
-14,940
| -23% | -$126K | ﹤0.01% | 5303 |
|
|
2023
Q4 | $535K | Buy |
65,593
+2,593
| +4% | +$20.4K | ﹤0.01% | 5057 |
|
|
2023
Q3 | $489K | Sell |
63,000
-7,295
| -10% | -$56.4K | ﹤0.01% | 4664 |
|
|
2023
Q2 | $531K | Buy |
70,295
+1,474
| +2% | +$11.2K | ﹤0.01% | 4773 |
|
|
2023
Q1 | $522K | Sell |
68,821
-4,161
| -6% | -$31.4K | ﹤0.01% | 4653 |
|
|
2022
Q4 | $515K | Buy |
72,982
+3,432
| +5% | +$24.7K | ﹤0.01% | 4674 |
|
|
2022
Q3 | $475K | Buy |
69,550
+9,000
| +15% | +$66.3K | ﹤0.01% | 4383 |
|
|
2022
Q2 | $447K | Sell |
60,550
-18,065
| -23% | -$143K | ﹤0.01% | 4341 |
|
|
2022
Q1 | $668K | Buy |
78,615
+9,820
| +14% | +$86.5K | ﹤0.01% | 4469 |
|
|
2021
Q4 | $639K | Buy |
68,795
+6,995
| +11% | +$66.1K | ﹤0.01% | 4779 |
|
|
2021
Q3 | $585K | Buy |
61,800
+11,500
| +23% | +$110K | ﹤0.01% | 4624 |
|
|
2021
Q2 | $483K | Sell |
50,300
-500
| -1% | -$4.73K | ﹤0.01% | 4762 |
|
|
2021
Q1 | $477K | Sell |
50,800
-8,100
| -14% | -$72.7K | ﹤0.01% | 4908 |
|
|
2020
Q4 | $500K | Sell |
58,900
-3,200
| -5% | -$25.9K | ﹤0.01% | 4599 |
|
|
2020
Q3 | $499K | Hold |
62,100
| – | – | ﹤0.01% | 4208 |
|
|
2020
Q2 | $476K | Buy |
62,100
+5,000
| +9% | +$36K | ﹤0.01% | 4183 |
|
|
2020
Q1 | $364K | Sell |
57,100
-2,500
| -4% | -$21.9K | ﹤0.01% | 4251 |
|
|
2019
Q4 | $551K | Sell |
59,600
-18,500
| -24% | -$169K | ﹤0.01% | 4760 |
|
|
2019
Q3 | $722K | Sell |
78,100
-60,000
| -43% | -$554K | ﹤0.01% | 4249 |
|
|
2019
Q2 | $1.29M | Buy |
138,100
+5,000
| +4% | +$45.2K | ﹤0.01% | 3538 |
|
|
2019
Q1 | $1.17M | Buy |
133,100
+24,515
| +23% | +$209K | ﹤0.01% | 3452 |
|
|
2018
Q4 | $834K | Buy |
108,585
+68,827
| +173% | +$579K | ﹤0.01% | 3842 |
|
|
2018
Q3 | $358K | Buy |
39,758
+4,258
| +12% | +$38.7K | ﹤0.01% | 4641 |
|
|
2018
Q2 | $326K | Sell |
35,500
-3,100
| -8% | -$28.7K | ﹤0.01% | 4631 |
|
|
2018
Q1 | $360K | Sell |
38,600
-900
| -2% | -$8.62K | ﹤0.01% | 4411 |
|
|
2017
Q4 | $372K | Buy |
+39,500
| New | +$390K | ﹤0.01% | 4502 |
|
UBS Group's DCF Position: Q4 2024 in Review
UBS Group sold out of BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (DCF) in Q4 2024, closing a stake of 130,782 shares — an estimated $1.2M sold.
UBS Group first reported a position in DCF in Q4 2017 and held it in 28 quarters. The position peaked at $1.29M in Q2 2019. 0 funds tracked by Wall St. Rank hold DCF as of Q4 2024.
- UBS Group reported no remaining BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. position as of Q4 2024 after selling out during the quarter.
- UBS Group sold 130,782 BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. shares in Q4 2024, an estimated $1.2M.
- UBS Group first reported a position in BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. in Q4 2017 and held it in 28 quarters.
- UBS Group's BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. position peaked at $1.29M in Q2 2019.
- 0 funds tracked by Wall St. Rank held BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. as of Q4 2024.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.